NCT05901545 2026-03-05Evaluating 111In Panitumumab for Nodal Staging in Head and Neck CancerVanderbilt-Ingram Cancer CenterPhase 1 Recruiting30 enrolled
NCT05747625 2025-12-19(89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell CarcinomaVanderbilt-Ingram Cancer CenterPhase 1 Recruiting60 enrolled
NCT05786924 2025-11-20Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesServierPhase 1/2 Recruiting554 enrolled